SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950142-08-001663
Filing Date
2008-10-10
Accepted
2008-10-10 12:36:49
Documents
2
Group Members
HARRI V. TARANTOMARK KESSELSYMPHONY CAPITAL GP, L.P.SYMPHONY CAPITAL PARTNERS, L.P.SYMPHONY GP, LLCSYMPHONY VIDA HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d_oxi.htm SC 13D 243335
2 JOINT FILING AGREEMENT exh1-sc13d_oxi.htm EX-99 26789
  Complete submission text file 0000950142-08-001663.txt   271863
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Subject) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45691 | Film No.: 081117713
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 950 PARK AVE APT. 11A NEW YORK NY 10028
Business Address
KESSEL MARK (Filed by) CIK: 0001222013 (see all company filings)

Type: SC 13D